For submissions click here.
Ted Ziemann, CEO of Armis Biopharma, has retired. He will continue to serve as chairman of the board of directors.
Kevin Chew is chief revenue officer for Pitcher.
Simon Bates has been elected to the board of directors of DMC Global as an independent director.
Jim Thomas will lead Project Genetics’s SOS Offerings. He is the vice president of sales.
Michael J. Voss has been appointed CEO of Armis Biopharma.
Drew Dix (Major USA Ret.) has joined the board of Stand Together Against Racism and Radicalism in the Services (STARRS).
Charles Arnold has been appointed to the board of directors for Rocky Mountain Chocolate Factory as chair of the audit committee.
For submissions click here.
Ted Ziemann, CEO of Armis Biopharma, has retired. He will continue to serve as chairman of the board of directors.
Kevin Chew is chief revenue officer for Pitcher.
Simon Bates has been elected to the board of directors of DMC Global as an independent director.
Jim Thomas will lead Project Genetics’s SOS Offerings. He is the vice president of sales.
Michael J. Voss has been appointed CEO of Armis Biopharma.
Drew Dix (Major USA Ret.) has joined the board of Stand Together Against Racism and Radicalism in the Services (STARRS).
Charles Arnold has been appointed to the board of directors for Rocky Mountain Chocolate Factory as chair of the audit committee.
